HIV Education and Risk Management

The Latest

Hormonal Contraception Does Not Increase HIV Risk, Study Finds

No meaningful difference was found in either injectable or implant birth control when compared to an IUD.

By Sony Salzman

Government Panel Finds PrEP Is Effective, Must Be Available Free of Cost to Patients

The US Preventive Services Task Force released its final ruling in JAMA.

By Kenyon Farrow

This Week in HIV Research: The Racism of Perceived Risk

June 6, 2019: HIV/STI risk perceptions differ by race; psychosocial issues and HIV risk among young trans women; switching to dolutegravir/atazanavir; reports of severe hepatotoxicity on dolutegravir.

By Barbara Jungwirth and Myles Helfand

New Campaign, Toolkit Gets Providers PrEP'd for Women

New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.

By Kenyon Farrow

This Week in HIV Research: Better Serving the Underserved

May 9, 2019: HIV care retention and viral suppression among transgender women; heating opioid use equipment to curb HIV transmission; managing HIV outbreaks among people who are homeless; improving viral suppression among people who use substances.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Disparities Drive the Epidemic

April 25, 2019: stigma and viral load among African-American women; U.S. HIV incidence sans racial disparities; the care continuum is failing young MSM; a moment of reckoning regarding HIV among U.S. youth.

By Barbara Jungwirth and Myles Helfand

Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C

"Providing HCV treatment alone while neglecting to concurrently address the social determinants of health will do little to improve the health outcomes of the majority of individuals with chronic HCV," the study authors wrote.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange

The Opioid Epidemic Is Fueling HIV Cluster Outbreaks -- Here's How the CDC is Responding

Epidemiologists are using a combination of molecular surveillance and tuberculosis-style contact tracing in hopes of helping local health departments curb HIV transmissions.

By Sony Salzman

Many Providers Are Biased Against Prescribing PrEP to People Who Inject Drugs

Health care providers often believe stereotypes that PWID are irresponsible and won't adhere to PrEP, according to data presented at the 2019 National HIV Prevention Conference.

By Sony Salzman

Chemsex Doesn't Impact PrEP Adherence, New Study Finds

Although people living with HIV who "party and play" appear more likely to struggle with treatment adherence, new research suggests that concern does not apply to PrEP.

By Sony Salzman